Cargando…

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma

SIMPLE SUMMARY: Intrinsic immunogenic cell death (ICD) property plays an important role in the prognosis and immune microenvironment of patients with lung adenocarcinoma (LUAD). In this study, we performed an overall multi-omics analysis of the intrinsic ICD property and developed a risk scoring sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xiaotian, Zhao, Dechang, Zhang, Xuewen, Ma, Yiyang, Zhang, Rusi, Huang, Zirui, Wang, Gongming, Guo, Guangran, Wang, Weidong, Wen, Yingsheng, Zhang, Lanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295033/ https://www.ncbi.nlm.nih.gov/pubmed/37372093 http://dx.doi.org/10.3390/biology12060808

Ejemplares similares

SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial‐mesenchymal transition (EMT) in lung adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Ten-year trends of the clinicopathological characteristics, surgical treatments and survival outcomes of operable lung cancer patients in monocenter: a retrospective cohort study
por: Zhao, Dechang, et al.
Publicado: (2023)

Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein
por: Yang, Longjun, et al.
Publicado: (2021)

Analysis of the tumor immune environment identifies an immune gene set–based prognostic signature in non-small cell lung cancer
por: Guo, Guangran, et al.
Publicado: (2022)

A tumor microenvironment gene set–Based prognostic signature for non-small-cell lung cancer
por: Wen, Yingsheng, et al.
Publicado: (2022)

The independent prognostic effect of marital status on non-small cell lung cancer patients: a population-based study
por: Zhao, Dechang, et al.
Publicado: (2023)

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
por: Yang, Longjun, et al.
Publicado: (2022)

The Independent Prognostic Effect of Lymph Node Dissection on Patients With Stage IA NSCLC With Different T Stages
por: Zhao, Dechang, et al.
Publicado: (2021)

Combining Plasma miRNAs and Computed Tomography Features to Differentiate the Nature of Pulmonary Nodules
por: Xi, Kexing, et al.
Publicado: (2019)

Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study
por: Zhang, Rusi, et al.
Publicado: (2020)

Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
por: Wang, Weidong, et al.
Publicado: (2020)

Development and validation of a preoperative noninvasive predictive model based on circular tumor DNA for lymph node metastasis in resectable non-small cell lung cancer
por: Zhang, Rusi, et al.
Publicado: (2020)

Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma
por: Zhang, Rusi, et al.
Publicado: (2022)

Impact of Different Types of Lymphadenectomy Combined With Different Extents of Tumor Resection on Survival Outcomes of Stage I Non-small-cell Lung Cancer: A Large-Cohort Real-World Study
por: Wang, Weidong, et al.
Publicado: (2019)

The value of preoperative Glasgow Prognostic Score and the C-Reactive Protein to Albumin Ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma
por: Yu, Xiangyang, et al.
Publicado: (2018)

Segmental resection is associated with decreased survival in patients with stage IA non-small cell lung cancer with a tumor size of 21–30 mm
por: Yu, Xiangyang, et al.
Publicado: (2021)

Extent of resection and lymph node evaluation in early stage metachronous second primary lung cancer: a population-based study
por: Zhang, Rusi, et al.
Publicado: (2020)

Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer
por: Chen, Yongqiang, et al.
Publicado: (2018)

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer
por: Miller, Lance D, et al.
Publicado: (2014)

First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution’s clinical practice experience
por: Yu, Xiangyang, et al.
Publicado: (2018)

Prognosis and distribution of lymph nodes metastases in resectable primary pulmonary lymphoepithelioma‐like carcinoma: A large cohort from a single center
por: Yu, Xiangyang, et al.
Publicado: (2018)

A new method for accurately localizing and resecting pulmonary nodules
por: Wang, Gongming, et al.
Publicado: (2020)

The transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes
por: Kazachenka, Anastasiya, et al.
Publicado: (2023)

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM
por: Feng, Songshan, et al.
Publicado: (2022)

A comparison of MASS-PCR and ARMS-PCR for the detection of lung cancer gene mutation
por: Cai, Ling, et al.
Publicado: (2019)

Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma
por: Peng, Wenguang, et al.
Publicado: (2023)

Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
por: Liu, Guohao, et al.
Publicado: (2022)

A Model Shows Utility in Predicting Postoperative Recurrence and Distant Metastasis in Curatively Resected Esophageal Squamous Cell Cancer
por: Wang, Weidong, et al.
Publicado: (2019)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes
por: Duan, Guangliang, et al.
Publicado: (2023)

M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
por: Zheng, Naisheng, et al.
Publicado: (2023)

Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

Immunogenic cell death-related long noncoding RNA influences immunotherapy against lung adenocarcinoma
por: SUN, DONGJIE, et al.
Publicado: (2023)

Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
por: Cao, Xi, et al.
Publicado: (2022)

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?
por: Chew, Hui Yi, et al.
Publicado: (2020)

Tumor cell plasticity and intrinsic immunogenicity: Implications for immunotherapy resistance in small‐cell lung cancer
por: Ruan, Ji
Publicado: (2021)

Delineating conditions and subtypes in chronic pain using neuroimaging
por: Holmes, Scott A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ao224bi1n98bl2c09r0hn71p8o